The admission process to Ferticentro's Oocyte Donation Program is particularly demanding and most of the candidates are not accepted, as it is especially important for us to ensure that the process is safe for both the donor and receiver couple. At Ferticentro, the oocyte donation is done in an ethical way, in which the privacy and rights of the donors are always respected and the treatment is carried out in the safest and least aggressive way possible.
To be admitted to the Ferticentro Oocyte Donation Program, donor candidates are evaluated by a multidisciplinary team, whose intervention focuses on medical parameters (general health status, infectious diseases, etc.), gynaecological (especially those affecting the actual and future fertility of the oocyte donors, besides the safety of the treatment), psychological (commitment to the donation process, screening of psychiatric illnesses, how they look at the donation process) and genetic (screening of the most common genetic diseases in the donor and evaluation of their family history).
In case of families with a history of particular genetic diseases, there is still the possibility to perform additional to the donors, and additional tests are also available to exclude rare genetic diseases - nowadays it is possible to select donors that are evaluated for sets of 600 or 250 genetic diseases (Recombine tests - https://clinics.recombine.com/diseases, CGT 250 - https://cgt.igenomix.com/cgt-250/ or CGT 600 - https://cgt.igenomix.com / cgt-600 /), and that in rare cases where the donor and the male partner of the receiver couple (or sperm donor, when applicable) are simultaneously carriers of the same genetic disorder, could be associated with a risk of 25 % of transmission of the disease to the child. For more information contact our services.
All donors admitted to Ferticentro's oocyte donation program underwent the following tests:
- Physical examination;
- Gynaecological examination with ultrasound scan;
- Evaluation of clinical history and family history of diseases;
- Psychological evaluation of the donor;
- Clinical analysis (to determine the general health status of the donor and her blood group with Rh factor and also to exclude possible infections with HIV 1 and 2, Hepatitis B and C, HTLV I / II and syphilis);
- Karyotype analysis, to exclude chromosomal alterations;
- Other genetic tests, performed in order to exclude the most common genetic diseases in the ethnic group to which the donor belongs (the screening of 50 mutations of the Cystic Fibrosis gene is always done to all donors, some donors are also tested to exclude diseases such as sickle cell anaemia, Fragile X syndrome, spinal muscular atrophy, hereditary congenital deafness, Friedreich's ataxia, recessive polycystic kidney disease, glucose-6-phosphate dehydrogenase deficiency or beta thalassemia).
Additional testing of donors has associated costs and is not included in the treatment price.
For more information and to get a clinical evaluation of your case, contact our services.
